Minerva Surgical (UTRS) Stock Price, News & Analysis

0.00 (0.00%)
(As of 05/2/2024)
Today's Range
50-Day Range
52-Week Range
26,100 shs
Average Volume
4,103 shs
Market Capitalization
P/E Ratio
Dividend Yield
Price Target
UTRS stock logo

About Minerva Surgical Stock (NASDAQ:UTRS)

Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States. The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps. Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices. The company was incorporated in 2008 and is headquartered in Santa Clara, California.

UTRS Stock Price History

UTRS Stock News Headlines

Minerva Surgical Inc.
Why Is Minerva Surgical (UTRS) Stock Down 50% Today?
Minerva Surgical Inc UTRS
Patent Grant Sends Healthcare Shares Soaring Premarket
Q1 2023 Minerva Surgical Inc Earnings Call
Piper Sandler Remains a Buy on Minerva Surgical (UTRS)
Q4 2022 Minerva Surgical Inc Earnings Call
Minerva Surgical Earnings Preview
See More Headlines
Receive UTRS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Minerva Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$50.29 million
Book Value
$11.52 per share


Free Float
Market Cap
Not Optionable
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Todd Usen (Age 57)
    President, CEO & Director
  • Mr. Greg Simbro
    Vice President of Finance
  • Mr. Erik Reese
    Vice President of Sales
  • Ms. Wendy Bowman
    Vice President of Human Resources
  • Dr. Evgueni V. Skalnyi M.D. (Age 58)
    Chief Medical Officer
    Comp: $365.25k
  • Ms. Joanne Long
    Vice President of Corporate Controller

UTRS Stock Analysis - Frequently Asked Questions

How have UTRS shares performed in 2024?

Minerva Surgical's stock was trading at $1.17 at the beginning of the year. Since then, UTRS shares have decreased by 99.9% and is now trading at $0.0010.
View the best growth stocks for 2024 here

How were Minerva Surgical's earnings last quarter?

Minerva Surgical, Inc. (NASDAQ:UTRS) posted its quarterly earnings results on Wednesday, December, 1st. The company reported ($23.00) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($8.80) by $14.20. The firm earned $12.51 million during the quarter, compared to analysts' expectations of $12.23 million. Minerva Surgical had a negative trailing twelve-month return on equity of 136.40% and a negative net margin of 64.71%.

When did Minerva Surgical's stock split?

Minerva Surgical's stock reverse split on Monday, October 2nd 2023. The 1-20 reverse split was announced on Monday, October 2nd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 2nd 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

When did Minerva Surgical IPO?

Minerva Surgical (UTRS) raised $100 million in an IPO on Friday, October 22nd 2021. The company issued 6,250,000 shares at a price of $15.00-$17.00 per share.

How do I buy shares of Minerva Surgical?

Shares of UTRS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:UTRS) was last updated on 5/20/2024 by Staff

From Our Partners